VEGF and Activated Eosinophils in Children with Asthma and Eosinophilic Bronchitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : Vascular endothelial growth factor (VEGF) is an important mediator of airway inflammation and remodeling in asthma. We aimed to explore whether VEGF is expressed at elevated levels in asthmatic airways or eosinophilic bronchitis (EB) and associated with eosinophilic inflammation, pulmonary function, and airway hyperresponsiveness (AHR) in children. Methods : One hundred seventeen asthmatic children, 77 children with EB, and 84 healthy children were enrolled. Sputum supernatants were collected and VEGF and eosinophil cationic protein (ECP) levels were measured. Results : Asthmatic children had significantly higher levels of VEGF in induced sputum [89.04 (29.95-178.09) pg/mL] compared to children with EB [25.30 (11.02-80.23) pg/mL] and healthy children [37.37 (16.56-71.30) pg/mL; P=0.0003]. VEGF in sputum positively correlated with sputum ECP (r=0.524; P<0.0001). Negative significant correlations were found between sputum VEGF and FEV1, (r=-0.252; P=0.001) or post-bronchodilator FEV1 (r=-0.181; P= 0.038) whereas nonsignificant correlations were found between sputum VEGF and sputum eosinophils. Conclusion : Our findings suggest that VEGF is associated with activated eosinophils in the asthmatic airway, but not EB. Sputum VEGF could be a supportive marker that represents activation of airway eosinophils and persistent airflow limitation in asthmatic children.
Abstract
Purpose : Vascular endothelial growth factor (VEGF) is an important mediator of airway inflammation and remodeling in asthma. We aimed to explore whether VEGF is expressed at elevated levels in asthmatic airways or eosinophilic bronchitis (EB) and associated with eosinophilic inflammation, pulmonary function, and airway hyperresponsiveness (AHR) in children. Methods : One hundred seventeen asthmatic children, 77 children with EB, and 84 healthy children were enrolled. Sputum supernatants were collected and VEGF and eosinophil cationic protein (ECP) levels were measured. Results : Asthmatic children had significantly higher levels of VEGF in induced sputum [89.04 (29.95-178.09) pg/mL] compared to children with EB [25.30 (11.02-80.23) pg/mL] and healthy children [37.37 (16.56-71.30) pg/mL; P=0.0003]. VEGF in sputum positively correlated with sputum ECP (r=0.524; P<0.0001). Negative significant correlations were found between sputum VEGF and FEV1, (r=-0.252; P=0.001) or post-bronchodilator FEV1 (r=-0.181; P= 0.038) whereas nonsignificant correlations were found between sputum VEGF and sputum eosinophils. Conclusion : Our findings suggest that VEGF is associated with activated eosinophils in the asthmatic airway, but not EB. Sputum VEGF could be a supportive marker that represents activation of airway eosinophils and persistent airflow limitation in asthmatic children.
참고문헌 (31)
- Jeffery PK, "Remodeling in asthma and chronic obstructive lung disease", Am J Respir Crit Care Med, 164, pp.S28~S38 (2001)
- Kim ES, "Basement membrane thickening and clinical features of children with asthma", Allergy, 62, pp.635~640 (2007)
- Saglani S, "Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers", Am J Respir Crit Care Med, 176, pp.858~864 (2007)
- Kay AB, "A role for eosinophils in airway remodelling in asthma", Trends Immunol, 25, pp.477~482 (2004)
- ten Brinke A, "Factors associated with persistent airflow limitation in severe asthma", Am J Respir Crit Care Med, 164, pp.744~748 (2001)
- Li X, "Increased vascularity of the bronchial mucosa in mild asthma", Am J Respir Crit Care Med, 156, pp.229~233 (1997)
- Orsida BE, "Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma", Am J Respir Crit Care Med, 164, pp.117~121 (2001)
- Feltis BN, "Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma", Am J Respir Crit Care Med, 173, pp.1201~1207 (2006)
- Folkman J, "Angiogenesis in cancer, vascular, rheumatoid and other disease", Nat Med, 1, pp.27~31 (1995)
- Simcock DE, "Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma", Am J Respir Crit Care Med, 176, pp.146~153 (2007)
- Asai K, "Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects", J Allergy Clin Immunol, 110, pp.571~575 (2002)
- Puxeddu I, "Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases", J Allergy Clin Immunol, 116, pp.531~536 (2005)
- Feistritzer C, "Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils", Am J Respir Cell Mol Biol, 30, pp.729~735 (2004)
- Brightling CE, "Eosinophilic bronchitis is an important cause of chronic cough", Am J Respir Crit Care Med, 160, pp.406~410 (1999)
- Brightling CE, "Comparison of airway immunopathology of eosinophilic bronchitis and asthma", Thorax, 58, pp.528~532 (2003)
- Siddiqui S, "Airway hyperresponsiveness is dissociated from airway wall structural remodeling", J Allergy Clin Immunol (2008)
- Brightling CE, "Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma", Clin Exp Allergy, 33, pp.1711~1716 (2003)
- Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
- Park SW, "Differences in radiological", HRCT findings in eosinophilic bronchitis and asthma: implication for bronchial responsiveness, 2006, pp.61, 41~47
- "Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007", J Allergy Clin Immunol, 120, pp.S94~S138 (2007)
- Brown WG, "The relationship of respiratory allergy, skin test reactivity, and serum IgE in a community population sample", J Allergy Clin Immunol, 63, pp.328~335 (1979)
- Backman A, "Skin tests for epidemiologic studies", Allergy, 49, pp.493~494 (1994)
- Standardization of Spirometry, , Am J Respir Crit Care Med, 152, pp.1107~1136 (1995)
- Yoshikawa T, "Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma", Eur Respir J, 12, pp.879~884 (1998)
- Abdel-Rahman AM, "A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack", Chest, 129, pp.266~271 (2006)
- Hossny E, "Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma", Pediatr Allergy Immunol (2008)
- Kanazawa H, "Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis", Am J Respir Crit Care Med, 169, pp.1125~1130 (2004)
- Siddiqui S, "Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis", J Allergy Clin Immunol, 120, pp.813~819 (2007)
- Leckie MJ, "Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response", Lancet, 356, pp.2144~2148 (2000)
- Lee YC, "Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma", J Immunol, 168, pp.3595~3600 (2002)